Human use of antimicrobial agents

OIE Revue Scientifique et Technique

Volumn 31, Issue 1, 2012, Pages 121-133

  Zarb, P ^a   Goossens, H ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Antimicrobial resistance; Antimicrobial stewardship; Human antimicrobial consumption; Legal classification of antimicrobials; Self medication; Surveillance; Veterinary antimicrobial consumption

Indexed keywords

ANIMALIA;

EID: 84864030022     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.31.1.2108     Document Type: Article

References (96)

1. Adriaenssens N., Coenen S., Muller A., Vankerckhoven V & Goossens H. (2010). - European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe. J. antimicrob. Chemother., 65 (4), 769-774.
2. Al-Azzam S.I., Al-Husein B.A., Akoubi E, Masadeh M.M. & Al-Horani M.A.S. (2007). - Self-medication with antibiotics in Jordanian population. Int.J. occup. Med. environ. Hhh, 20 (4), 373-380.
3. Allerberger E, Frank A. & Gareis R. (2008). - Antibiotic stewardship through the EU project 'ABS International'. Wien. khn. Wochenschr, 120 (9-10), 256-263. (Pubitemid 351845333)
4. Amadeo B., Zarb R, Muller A., Drapier N., Vankerckhoven V, Rogues A., Davey R & Goossens H. (2010). - European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J. antimicrob. Chemother., 65 (10), 2247-2252.
5. Anon. (1998). - House of Lords inquiry into antimicrobial resistance. Communie. Dis. Rep. CDR weekly, 8 (17), 147-150.
6. Ansari F, Emtell M., Goossens H. & Davey R (2009). - The European Surveillance of Antimicrobial Consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin, infect. Dis., 49 (10), 1496-1504.
7. Ansari E, Molana H., Goossens H. & Davey R (2010). -Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-2006. J. antimicrob. aemother., 65 (12), 2685-2691.
8. Awad A., Eltayeb I., Matowe L. & Thalib L. (2005). - Self-medication with antibiotics and antimalarials in the community of Khartoum State, Sudan. J. pharmaceut. Sci., 8 (2), 326-331. (Pubitemid 41519145)
9. Berzanskyte A., Vahntehene R., Haaijer-Ruskamp EM., Gurevicius R. & Grigoryan L. (2006). - Self-medication with antibiotics in Lithuania. Int. J. occup. Med. environ. Hlth, 19 (4), 246-253. (Pubitemid 46212461)
10. Bi R, Tong S. & Parton K.A. (2000). - Family self-medication and antibiotics abuse for children and juveniles in a Chinese city Social Sci. Med., 50 (10), 1445-1450. (Pubitemid 30100390)
11. Borg M.A., Cookson B.D., Zarb R & Scicluna E.A. (2009). -Antibiotic resistance surveillance and control in the Mediterranean region: report of the ARMed consensus conference.J. Infect, dev. Countries., 3 (9), 654-659.
12. Borg M.A., Zarb R, Ferech M. & Goossens H. (2008). -Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project. J. antimicrob. Chemother., 62 (4), 830-836.
13. Bronzwaer S.L., Buchholz U. & Kool J.L. (2001). -International surveillance of antimicrobial resistance in Europe: now we also need to monitor antibiotic use. Eurosurveillance, 6 (1), pii=225. Available at: www.euro surveillance.orgA^iewArticle.aspx?ArticleId=225.
14. Bud R. (2007). - Antibiotics: the epitome of a wonder drug. BMJ, 334 (Suppl. 1), S6.
15. Cameron S.T. (2009). - Patient-delivered partner therapy for chlamydia: a reahstic public health measure in the UK. BJOG, 116(3), 345-346.
16. Cameron S.T., Melvin L, Glasier A., Scott G.Johnstone A. & Young H. (2007). - Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of w^omen with chlamydia. BJOG, 114 (12), 1516-1521. (Pubitemid 350077427)
17. Campos J., Ferech M., Lázaro E., de Abajo E, Oteo J., Stephens P. & Goossens H. (2007). - Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data.J antimicrob. Chemother., 60 (3). 698-701. (Pubitemid 47299895)
18. Carrasco-Garrido P, Jiménez-García R., Barrera VH. & Gil de Miguel A. (2008). - Predictive factors of self-medicated drug use among the Spanish adult population. Pharmacoepidemiol Drug Sa J., 17 (2), 193-199. (Pubitemid 351308519)
19. Charies LJ., van der Kaay HJ., Vincke I.H. & Brady J. (1962). - The appearance of pyrimethamine resistance in Plasmodium Jalciparum follovnng self-medication by a rural community in Ghana. Bull WHO, 26, 103-108.
20. Coenen S., Ferech M., Dvorakova K., Hendrickx E., Suetens C. & Goossens H. (2006). - European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.J antimicrob. Chemother., 58 (2), 413-417. (Pubitemid 44294956)
21. Coenen S., Ferech M., Haaijer-Ruskamp EM., Butler C.C., Vander Stichele R.H., Verheij TJ.M., Monnet D.L., Litde R & Goossens H. (2007). - European surveillance of antimicrobial consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual SaJ. Health Care, 16 (6), 440-445.
22. Coenen S., Ferech M., Malhotra-Kumar S., Hendrickx E., Suetens C. & Goossens H. (2006). - European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe.J antimicrob. Chemother., 58 (2), 418-422. (Pubitemid 44294957)
23. Coenen S., Muller A., Adriaenssens N., Vankerckhoven V, Hendrickx E. & Goossens H. (2009). - European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe.J antimicrob. Chemother, 64 (1), 200-205.
24. Davey R, Ferech M., Ansari F, Muller A. & Goossens H. (2008). - Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J antimicrob. Chemother., 62 (6), 1441-1447.
25. Davey R, Pagliari C. & Hayes A. (2002). - The patient's role in the spread and control of bacterial resistance to antibiotics. Clin. Microbiol Inject., 8 (Suppl. 2), 43-68. (Pubitemid 35203499)
26. Davey P, Sneddon J. & Nathwani D. (2010). - Overview of strategies for overcoming the challenge of antimicrobial resistance. Expert Rev. din. Pharmacol, 3 (5), 667-686.
27. Dellit TH., Owens R.C., McGowan J.E.J., Gerding D.N., Weinstein R.A., Burke J.R, Huskins WC., Paterson D.L., Fishman N.O., Carpenter C.F, Brennan PJ., Billeter M. & Hooton T.M. (2007). - Infectious Diseases Society of America and the Society for Heakhcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Ciin. inject. Dis., 44 (2), 159-177. (Pubitemid 46084814)
28. Donohue J.M., Cevasco M. & Rosenthal M.B. (2007). - A decade of direct-to-consumer advertising of prescription drugs. N. Engl.J Med., 357 (7), 673-681. (Pubitemid 47267237)
29. Dryden M.S., Cooke J. & Davey P (2009). - Antibiotic stewardship: more education and regulation not more availabihty? J. antimicrob. Chemother., 64 (5), 885-888.
30. Elseviers M.M., Ferech M., Vander Stichele R.H. & Goossens H. (2007). - Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol. Drug SaJ, 16(1), 115-123. (Pubitemid 46164984)
31. European Commission (2000). - Commission Decision of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No. 2119/98/EC of the European Parliament and of the Council (2000/96/EC). OJJ J. Eur Communities, L 28, 50-53.
32. European Council (2002). - Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). OJJ. J. Eur Communities, L 34, 13-16.
33. European Medicines Agency (EMEA) (2010). - European Surveillance of Veterinary Antimicrobial Consumption (ESVAC). Data collection protocol (ema/194976/2010). EMEA, London. Available at: www.emea.europa. eu/docs/en-GB/document-hbrary/Other/2010/04AVC50008 9584.pdf (accessed on 25 January 2011).
34. European Medicines Agency (EMEA) (2010). - European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) (ema/788319/2009). Report of a meeting held on 25 November 2009 at the EMEA. Available at: www.emea. europa.eu/docs/en-GB/document-library/Report/2010/02/W C500070815.pdf (accessed on 25 January 2011).
35. Ferech M. (2004). - European Surveillance of Antimicrobial Consumption: the ESAC programme. Eurosurveillance, 8 (32), pii=2518. Available at: www.eurosurveillance.org/ ViewArticle. aspx?ArticleId=2 518.
36. Ferech M., Coenen S., Dvorakova K., Hendrickx E., Suetens C. & Goossens H. (2006). - European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J. antimicrob. Chemother., 58 (2), 408-412. (Pubitemid 44294955)
37. Ferech M., Coenen S., Malhotra-Kumar S., Dvorakova K., Hendrickx E., Suetens C. & Goossens H. (2006). - European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.J antimicrob. Chemother., 58 (2), 401-407. (Pubitemid 44294954)
38. Ferech M., Coenen S., Malhotra-Kumar S., Dvorakova K., Hendrickx E., Suetens C. & Goossens H. (2006). - European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J. antimicrob. Chemother., 58 (2), 423-427. (Pubitemid 44294958)
39. Goossens H., Ferech M., Coenen S. & Stephens P. (2007). -Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin, infect. Dis., 44 (8), 1091-1095. (Pubitemid 46580279)
40. Goossens H., Ferech M., Vander Stichele R. & Elseviers M. (2005). - Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet, 365 (9459), 579-587. (Pubitemid 40247914)
41. Gordon S.M., Mosure D.J., Lewis J., Brown S., McNagny S.E. & Schmid G.R (1993). - Prevalence of self-medication with antibiotics among patients attending a clinic for treatment of sexually transmitted diseases. Clin, infect. Dis., 17 (3), 462-465. (Pubitemid 23261464)
42. Grave K., Torren-Edo J. & Mackay D. (2010). - Comparison of the sales of veterinary antibacterial agents between 10 European countries. J. antimicrob. Chemother., 65 (9), 2037-2040.
43. Grigoryan L., Burgerhof J.G.M., Degener J.E., Deschepper R., Lundborg C.S., Monnet D.L., Scicluna E.A., Birkin J. & Haaijer-Ruskamp EM. (2007). - Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study Pharmacoepidemiol. Drug Saf, 16 (11), 1234-1243. (Pubitemid 350120649)
44. Grigoryan L., Burgerhof J.G.M., Degener J.E., Deschepper R., Lundborg C.S., Monnet D.L., Scicluna E.A., Birkin J. & Haaijer-Ruskamp FM. (2008). - Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J. antimicrob. Chemother., 61 (5), 1172-1179. (Pubitemid 351524467)
45. Grigoryan L., Burgerhof J.G.M., Haaijer-Ruskamp EM., Degener J.E., Deschepper R., Monnet D.L., Di Matteo A., Scicluna E.A., Bara A., Lundborg C.S. & Birkin J. (2007). - Is self-medication with antibiotics in Europe driven by prescribed use? J. antimicrob. Chemother., 59 (1), 152-156. (Pubitemid 46017920)
46. Grigoryan L., Haaijer-Ruskamp EM., Burgerhof J.G.M., Mechtler R., Deschepper R., Tambic-Andrasevic A., Andrajati R., Monnet D.L., Cunney R., Di Matteo A., Edelstein H., Valinteliene R., Alkerwi A., Scicluna E., Grzesiowski R, Bara A., Tesar T., Cizman M., Campos J., Lundborg C.S. & Birkin J. (2006). - Self-medication with antimicrobial drugs in Europe. Emerg. infect. Dis., 12 (3), 452-459.
47. Guillemot D. (1999). - Antibiotic use in humans and bacterial resistance. Curr Op. Microbiol., 2 (5), 494-498. (Pubitemid 29477175)
48. Hammerum A.M., Heuer O.E., Lester C.H., Agerso Y., Seyfarth A.M., Emborg H., Frimodt-Moller N. & Monnet D.L. (2007). - Comment on: withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Int. J. antimicrob. Agents, 30 (5), 466-468. (Pubitemid 47498972)
49. Harrison J.W & Svec T.A. (1998). - The beginning of the end of the antibiotic era? Part 1. The problem: abuse of the 'miracle drugs'. Quintessence Int., 29 (3), 151-162. (Pubitemid 128687173)
50. Henderson K.L., Müller-Pebody B., Johnson A.P, Goossens H. & Shariand M. (2009). - First set-up meeting for Antibiotic Resistance and Prescribing in European Children (ARPEC). Eurosurveillance, 14 (45). Available at: www.eurosurveillance.orgA'iewArticle.aspx?ArticleId=1940.
51. Keuleyan E. & Gould M. (2001). - Key issues in developing antibiotic policies: from an institutional level to Europe-wide. European Study Group on Antibiotic Policy (ESGAP), Subgroup III. Clin. Microbiol. Infect., 7 (Suppl. 6), 16-21. (Pubitemid 33730239)
52. Kumar A., Roberts D., Wood KE., Light B , Parrillo J.E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., Gurka D., Kumar A. & Cheang M. (2006). - Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med., 34 (6), 1589-1596. (Pubitemid 43810035)
53. Kuster S.P, Ruef C., Ledergerber B., Hintermann A., Deplazes C., Neuber L. & Weber R. (2008). - Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection, 36 (6), 549-559.
54. Levy S.B. (2002). - The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. J. antimicrob. Chemother., 49 (1), 25-30. (Pubitemid 34100643)
55. Li L. & Wang R (2005). - Self-medication with antibiotics: a possible cause of bacterial resistance. Med. Hypoth., 65 (5), 1000-1001.
56. Livermore D. (2004). - Can better prescribing turn the tide of resistance? Nat. Rev. Microbiol, 2 (1), 73-78. (Pubitemid 39490050)
57. Livermore D.M. (2004). - The need for new antibiotics. Clin. Microbiol Infect., 10 (Suppl. 4), 1-9.
58. Llor C. & Cots J.M. (2009). - The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin, infect. Dis., 48 (10), 1345-1349.
59. Macfarlane J.T. & Worboys M. (2008). - The changing management of acute bronchitis in Britain, 1940-1970: the impact of antibiotics. Med. Hist., 52 (1), 47-72.
60. MacKenzie FM., Monnet D.L. & Gould I.M. (2006). -Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J. antimicrob. Chemother., 58 (3), 657-660. (Pubitemid 44288134)
61. MacKenzie EM., Struelens MJ., Towner KJ. 65: Gould I.M. (2005). - Repon of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin. Microbiol Infect., 11 (11), 938-954. (Pubitemid 41535937)
62. Mainous A.G., Everett C.J., Post R.E., Diaz VA. & Hueston WJ. (2009). - Availability of antibiotics for purchase without a prescription on the internet. Ann. Fam. Med., 7 (5), 431-435.
63. Marzluf M.J. (1972). - Penicillin: still a wonder drug. Bedside Nurse, 5 (4), 19-20.
64. Matuz M., Benko R., Doro R, Hajdu E. Soos G. (2007). -Non-prescription antibiotic use in Hungary. Pharm. World Sci., 29 (6), 695-698. (Pubitemid 47594183)
65. Metz-Gercek S. & Mittermayer H. (2008). - The European surveillance activities EARSS and ESAC in the context of ABS International. Wien. klin. Wochenschr., 120 (9-10), 264-267. (Pubitemid 351845334)
66. Morris J.N. (2004). - Recalling the miracle that was penicillin: two memorable patients. J. roy. Soc. Med., 97 (4), 189-190. (Pubitemid 38496963)
67. Muller A., Coenen S., Monnet D.L. & Goossens H. (2007). -European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Eurosurveillance, 12 (41). Available at: www. eurosurveillance.orgA^iewArticle.aspx?ArticleId=3284.
68. Mulvey M.R., Grant J.M., Plewes K., Roscoe D. & Boyd D.A. (2011). - New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg. infect. Dis., 17 (1), 103-106.
69. Muscat M., Monnet D.L., Klemmensen T., Grigoryan L., Jensen M.H., Andersen M. & Haaijer-Ruskamp EM. (2006). -Patterns of antibiotic use in the community in Denmark. Scand. J. infect. Dis., 38 (8), 597-603. (Pubitemid 44144715)
70. Niederman M.S. & Berger J.T. (2010). - The delivery of futile care is harmful to other patients. Crit. Care Med., 38 (Suppl. 10), S518-522.
71. Paterson D.L. (2004). - 'Collateral damage' from cephalosporin or quinolone antibiotic therapy Clin, infect. Dis., 38 (Suppl. 4), S341-345. (Pubitemid 38669889)
72. Phillips I. (2007). - Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Int.J. antimicrob. Agents, 30 (2), 101-107. (Pubitemid 46977184)
73. Plachouras D., Kavatha D., Antoniadou A., Giannitsioti E., Poulakou G., Kanellakopoulou K. & Giamarellou H. (2010). -Dispensing of antibiotics wdthout prescription in Greece, 2008: another link in the antibiotic resistance chain. Eurosurveillance, 15 (7), pii=19488. Available at: www. eurosurveillance.orgAiewArticle.aspx?ArticleId=19488.
74. Radyowijati A. & Haak H. (2003). - Improving antibiotic use in low-income countries: an overview of evidence on determinants. Social Sci. Med., 57 (4), 733-744. (Pubitemid 36765367)
75. Raz R., Edelstein H., Grigoryan L. & Haaijer-Ruskamp EM. (2005). - Self-medication with antibiotics by a population in northern Israel. Isr med. Assoc. J., 7 (11), 722-725. (Pubitemid 41700797)
76. Reeves D. (2007). - The 2005 Garrod lecture: the changing access of patients to antibiotics: for better or worse? J. antimicrob. Chemother., 59 (3), 333-341. (Pubitemid 47073439)
77. Risnes K.R., Belanger K., Murk W & Bracken M.B. (2011). -Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am. J. Epidemiol, 173 (3), 310-318.
78. Rogues A.M., Dumartin C., Amadéo B., Venier A.G., Marty N., Pameix P & Gachie J.R (2007). - Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Infect. Control Hosp. Epidemiol, 28 (12), 1389-1395. (Pubitemid 351412089)
79. Sawair FA., Baqain Z.H., Abu Karaky A. & Abu Eid R. (2009). - Assessment of self-medication of antibiotics in a Jordanian population. Med. Princ. Pract., 18 (1), 21-25.
80. Shivasankar S. & Challenor R. (2008). - Patient-delivered partner therapy in the UK: what do the professionals think? Int. J. STDAIDS, 19 (7), 437-440.
81. Shivasankar S., Challenor R. Ekanayaka R. (2008). -Patient-delivered partner therapy in the UK: what do patients think? Int.J. STDAIDS, 19 (7), 433-436.
82. Silver L.L. (2011). - Challenges of antibacterial discovery Gin. Microbiol Rev., 24 (1), 71-109.
83. Struwe J. (2008). - Fighting antibiotic resistance in Sweden: past, present and future. Wien. klin. Wochenschr., 120 (9-10), 268-279. (Pubitemid 351845344)
84. Svensson E., Haaijer-Ruskamp EM. & Lundborg C.S. (2004). - Self-medication with antibiotics in a Swedish general population. Scand. J. infect. Dis., 36 (6-7), 450-452. (Pubitemid 39099103)
85. Taylor B. (2008). - Developments in pharmacy-based sexual health services. J. Fam. Plann. reprod. Health Care, 34 (3), 143-145. (Pubitemid 351976274)
86. United States Department of Health and Human Services Food and Drug Administration Center for Veterinary Medicine (2010). - The judicious use of medically important antimicrobial drugs in food-producing animals. Available at: www.fda.gov/dovmloads/AnimalVeterinary/GuidanceCompli anceEnforcement/ GuidanceforIndustry/UCM216936.pdf.
87. Vâânànen M.H., Pietilâ K. & Airaksinen M. (2006). - Self-medication with antibiotics: does it really happen in Europe? Health Policy, 77 (2), 166-171. (Pubitemid 43744380)
88. Van de Sande-Bruinsma N., Grundmann H., Verloo D., Tiemersma E., Monen J., Goossens H. & Ferech M. (2008). -Antimicrobial drug use and resistance in Europe. Emerg. inject. Dis., 14 (11), 1722-1730.
89. Vander Stichele R.H., Elseviers M.M., Ferech M., Blot S. & Goossens H. (2004). - European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach. Br J. din. Pharmacol, 58 (4), 419-428. (Pubitemid 39312466)
90. Vander Stichele R.H., Elseviers M.M., Eerech M., Blot S. & Goossens H. (2006). - Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997-2002). J. antimicrob. Chemother., 58 (1), 159-167. (Pubitemid 44295000)
91. Willemsen I., Bogaers-Hofman D., Winters M. & Kluytmans J. (2009). - Correlation between antibiotic use and resistance in a hospital: temporary and ward-specific observations. Infection, 37 (5), 432-437.
92. Zarb P., Amadeo B., Muller A., Drapier N., Vankerckhoven V, Davey P & Goossens H. (2011). - Identification of targets for quahty improvement in antimicrobial prescribing: the web-based ESAC point prevalence survey 2009. J. antimicrob. Chemother., 66 (2), 443-449.
93. Zarb P, Ansari E, Muller A., Vankerckhoven V, Davey EG. & Goossens H. (2011). - Drug utilization 75% (DU75%) in 17 European hospitals (2000-2005): results from the ESAC-2 hospital care sub project. Curr din. Pharmacol., 6 (1), 62-70.
94. Zarb R & Goossens H. (2011). - European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs, 71 (6), 745-755.
95. Zarfel G., Hoenigl M., Leitner E., Salzer H.J E, Feierl G., Masoud L, Valentin T., Krause R. & Grisold AJ. (2011). -Emergence of New Delhi metallo-P-lactamase, Austria. Emerg. infect. Dis., 17 (1), 129-130.
96. Zinner S.H. (2007). - Antibiotic use; present and future. New Microbiol, 30 (3), 321-325.